In mid-January 2026, Bernstein upgraded Vertex Pharmaceuticals to Outperform and UBS initiated coverage with a Buy rating, ...

ORIC Pharmaceuticals recently drew investor attention with positive analyst commentary, new clinical data on its lead ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the last decade, the volume of clinical trial data has surged, presenting unprecedented ...

The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. By 2020, U.S. healthcare data had reached 2,314 exabytes—15 times more than in 2013—thanks ...

Rapport Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision medicines for neurological and psychiatric disorders, is hosting its first Investor and Analyst Day ...

Real-world data is invaluable to healthcare tech developers. This type of data reflects actual patient experiences, treatments and outcomes in diverse, real-world environments — rather than controlled ...

Cabaletta Bio, Inc. announced promising clinical data regarding its investigational therapy, resecabtagene autoleucel (rese-cel), for autoimmune diseases during recent scientific meetings. Among the ...